Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
about
The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's DiseasePsychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.Neuropsychiatric Issues in Parkinson's Disease.Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.Pimavanserin: A Novel Antipsychotic for Parkinson's Disease Psychosis.Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease.Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.[Evidence-based treatment of psychosis associated with Parkinson's disease].
P2860
Q26738456-2469A0B4-5955-41C3-8184-2BFA7B4CFA30Q30249553-6CBDA2A3-B0EC-46DE-8E87-D35F46371E01Q34388686-735F66B9-DCF1-4965-9FB7-1F6A4DB68170Q35124915-F2862DF4-3149-4177-8FDB-FF7050F163CAQ38258699-7A6F0733-A581-478F-9840-B85C9CE1F9F9Q38799051-322D0D6D-7B90-4AC8-BF0C-7CF9C1A6E42AQ38849634-D7BDB767-6054-498F-96C6-DB242844A922Q38856074-55DD1D21-68CF-4E25-BE72-0ACBF636DDB2Q38894971-36773E70-BB9B-488C-BB0F-6D12FA84AB57Q39004255-FF5CEC75-FE7B-413B-B16F-D8D7C3F95F39Q41812925-6B4BA1C6-A954-4157-9082-F0220DA49642Q43375910-4C50CAF6-CF80-4010-9CA5-56B9F083AE01Q47794742-B18AC175-8F90-42F7-A565-EBDB245D50E0Q53651478-73D963F3-0F7A-4748-ACB8-31D2DC5A1E09
P2860
Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Ziprasidone versus clozapine i ...... andomized open clinical trial.
@en
Ziprasidone versus clozapine i ...... andomized open clinical trial.
@nl
type
label
Ziprasidone versus clozapine i ...... andomized open clinical trial.
@en
Ziprasidone versus clozapine i ...... andomized open clinical trial.
@nl
prefLabel
Ziprasidone versus clozapine i ...... andomized open clinical trial.
@en
Ziprasidone versus clozapine i ...... andomized open clinical trial.
@nl
P2093
P1476
Ziprasidone versus clozapine i ...... andomized open clinical trial.
@en
P2093
Armando Muñiz
Eduard Tolosa
Luis Pintor
María José Martí
P356
10.1097/WNF.0B013E31824D5115
P577
2012-03-01T00:00:00Z